
News|Videos|September 2, 2016
What a Carcinoid Cancer Diagnosis Means
Advertisement
Episodes in this series

Advertisement
Related to this article

A cancer survivor shares what to say, what not to say and how listening can help support someone through cancer treatment and beyond.

The investigational drug, first developed for brain cancer, is being tested to see whether it can make resistant tumors respond to treatment again.

FDA approves Inluriyo plus Verzenio for adults with ESR1-mutated, ER-positive, HER2-negative advanced or metastatic breast cancer after endocrine therapy.

A phase 1 trial treated 15 patients with breast cancer that spread to the spinal fluid using a vaccine made from their own immune cells. One patient is now more than three years from diagnosis.
Advertisement
Advertisement
Trending on CURE
1
The Growing Role of AI in Cancer Care
2
Blood Cancer Treatments in the FDA Pipeline: What Could Come Next
3
3 More Lung Cancer Breakthroughs From WCLC 2026
4
Why Some Stage 3 Lung Cancers Don't Respond to Treatment, and What Researchers Are Trying Next
5




















